Among a handful of Indian pharma companies working in the area of biologics
Among a handful of Indian pharma companies working in the area of biologics
First and only listed ‘pure play’ biopharmaceuticals company in India
Globally recognised biopharmaceuticals enterprise with a unique business model that straddles both products and services
Extensive experience and demonstrated expertise in taking two novel biologics and five biosimilars from ‘lab to market’
Diversified portfolio of biosimilar insulin analogs and antibodies in advanced stages of development
400-member strong scientific team, including MDs, PhDs and Masters degree holders, drawn from within India and global biopharma organisations
In-house expertise across the drug value chain; pipeline includes proprietary and partnered programs
Incisive intellectual property strategy recognised by several national and international awards
Experience of multiple global regulatory filings in insulins, biosimilar antibodies and complex generic formulations